Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02230813
Other study ID # 14/53
Secondary ID
Status Completed
Phase N/A
First received August 29, 2014
Last updated January 25, 2017
Start date March 2015
Est. completion date September 27, 2016

Study information

Verified date January 2017
Source Royal College of Surgeons, Ireland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The term cellulitis is a medical term describing a bacterial infection of the skin and tissues beneath the skin. Although it is usually easily treated with antibiotics given either orally or through a vein (intravenously), knowing which route of antibiotic treatment to prescribe to a person attending an Emergency Department with cellulitis is not clear.

A Clinical Prediction rule (CPR) is a decision-making tool that comes from original research as opposed to the opinion of experts. We intend to create a preliminary CPR to decide which patients require oral and which patients require intravenous antibiotics for cellulitis from their first visit to an emergency department. The aim of this is to provide safer care by reducing the risk of a patient returning to the hospital with a worsening infection. It will also promote more cost-effective care by reducing hospital re-attendance rates and wasted antibiotics.

Patients attending the department with cellulitis who are suitable for oral antibiotic treatment will be enrolled into this study. A separate doctor will re-examine at least 10% of study participants in order to reduce bias. A set of physical signs and symptoms will be recorded from each patient in order to determine which ones are associated with them "failing" prescribed oral treatment. A study investigator will then phone the patient after 14 days to see whether they are better or whether they required intravenous antibiotics to get better.


Recruitment information / eligibility

Status Completed
Enrollment 152
Est. completion date September 27, 2016
Est. primary completion date September 27, 2016
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Age >16 years

- Suitable for treatment with flucloxacillin 500mg -1gram qds monotherapy or a suitable alternative for penicillin allergic patients as listed in the local prescribing guidelines.

- Appearance of typical, plaque-like area of erythema over any body part excluding the perineum within the preceding 5 days with any 2 of the following signs:

- 1.Increased warmth over affected area

- 2.Swelling of affected area

- 3.Pain over affected area

- 4.Regional lymphadenopathy

Exclusion Criteria:

- Requirement for IV antibiotics as decided by the treating clinician.

- Age less than 16 years.

- No telephone or access to a telephone.

- Abscess alone without co-existing signs of cellulitis

- Mammalian bite wounds.

- Infected diabetic foot ulcer

- Necrotising soft tissue infections.

- Perineal cellulitis.

- Suspected septic arthritis or osteomyelitis.

- Decubitus ulcers.

- Bilateral cellulitis (as this entity rarely exists).

- Acute lipodermatosclerosis.

- Acute dermatitis.

- Venous stasis dermatitis.

- Deep vein thrombosis.

- Pregnancy.

- Cognitive impairment.

- Any patient who through language barrier or diminished capacity is unable to understand the scope of the study

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Ireland Emergency Department Beaumont Hospital Dublin
Ireland Mater Misericoridiae University Hospital Dublin
Ireland Connolly Hospital Banchardstown Dublin 15

Sponsors (1)

Lead Sponsor Collaborator
Royal College of Surgeons, Ireland

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Treatment failure The primary outcome is the proportion of patients initially commenced on oral antibiotics who subsequently require IV antibiotics to achieve treatment response. This will be assessed by means of telephone follow-up performed at 14 days post enrolment into the study. Treatment failure is defined as attendance at a treating Emergency Department for intravenous antibiotic therapy if already commenced on oral therapy. 2 weeks post commencement of oral treatment
Secondary Treatment failure - change in type or dose Treatment failure measured by change in prescribed oral antibiotic to another oral antibiotic.
Treatment failure measured by change in prescribed dose of oral antibiotic to a higher dose of the same antibiotic
2 weeks
Secondary Inter-observer reliability for candidate predictor variables Assessment of inter-observer reliability for the candidate predictor variables listed. This will be performed in at least 10% of patients enrolled into the study by a second recruiting clinician. At enrolment
Secondary Loss to follow up Assessment of the loss to follow-up rate and usefulness of the data collection proforma in the pilot study will also prove valuable for planning for the live study. 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT02864420 - Hospitalization at Home: The Acute Care Home Hospital Program for Adults N/A
Completed NCT00746109 - Study of Wound Packing After Superficial Skin Abscess Drainage Phase 4
Completed NCT03296280 - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Not yet recruiting NCT01947660 - Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery N/A
Completed NCT01876628 - Adjunctive Clindamycin for Cellulitis: C4C Trial. Phase 4
Active, not recruiting NCT01706913 - Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis N/A
Completed NCT03474523 - Effectiveness of Diathermy-Radiofrecuency Compared With Cavitation in Cellulitis Treatment N/A
Recruiting NCT03312946 - Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite. N/A
Active, not recruiting NCT05226260 - Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care N/A
Active, not recruiting NCT03785834 - The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis
Completed NCT01549613 - Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Phase 4
Completed NCT01029782 - Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis Phase 2
Completed NCT00676130 - Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients N/A
Not yet recruiting NCT03917134 - Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy N/A
Completed NCT01557426 - Soft Tissue Ultrasound of Infections Phase 1
Completed NCT01339091 - Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Phase 3
Completed NCT00984022 - Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage Phase 2
Completed NCT04091672 - RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction N/A
Completed NCT05023200 - The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study
Terminated NCT02087527 - Use of Corticosteroids in Children With Cellulitis N/A